Phase 2 Macular Degeneration Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are willing and able to sign a consent form agreeing to take part in the study
• You are a man or woman between 50 and 85 years old and have been diagnosed with wet age-related macular degeneration (wet AMD)
• You are currently receiving anti-VEGF injections for wet AMD and have had at least 3 injections in the 6 months before the screening visit
• Your eye has shown a positive response to the anti-VEGF injections, meaning there has been a measurable reduction in fluid or swelling in the back of your eye
• Your vision in the study eye falls within a specific range — not too strong and not too weak (confirm with trial site for exact details)
• The study eye has already had a lens implant (cataract surgery) at least 3 months before joining the trial
• If you are female, you must have gone through menopause at least 1 year ago

Who may not be able to join:

• Your macular or central vision problems are caused by something other than wet AMD, such as severe short-sightedness or another eye disease
• There is something in or around your study eye (such as cloudiness or an implant) that would make it difficult to examine the back of the eye, or your pupil is too small to allow proper examination
• You have had, or currently have, a detached retina in the study eye
• You have glaucoma or high pressure in the eye that is not well controlled
• You have taken any medication known to be harmful to the retina
• You have had any surgery inside the study eye
• You have high blood pressure that is not well controlled, even with medication, at the time of your screening visit

Important: Always verify eligibility with the trial site directly before applying.